- Volume 17 Issue 7
DOI QR Code
Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer
- Kanthiya, Kanjana (Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University) ;
- Khunnarong, Jakkapan (Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University) ;
- Tangjitgamol, Siriwan (Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University) ;
- Puripat, Napaporn (Department of Anatomical Pathology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University) ;
- Tanvanich, Sujitra (Department of Anatomical Pathology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University)
- Published : 2016.07.01
Purpose: To evaluate the expression of p16 and Ki67 in cervical intraepithelial neoplasia (CIN) and cancer. Materials and Methods: We performed a immunohistochemical study of p16 and Ki67 in 243 cervical tissues - 53 non-dysplastic lesions, 106 CIN1, 61 CIN2/3 and 23 squamous cell carcinomas. The expression of p16 and Ki67 was interpreted independently by 2 researchers and the sensitivity and specificity to detect clinically significant lesions (
p16;Ki67;immunohostochemical study;cervical intraepithelial neoplasia;cancer
- Kim SM, Lee JU, Lee DW, Kim MJ, Lee HN (2011). The prognostic significance of P16, Ki-67, P63, and CK17 expression determined by immunohistochemical staining in cervical intraepithelial neoplasia 1. Korean J Obstet Gynecol, 54, 184-91. https://doi.org/10.5468/KJOG.2011.54.4.184
- Kostopoulou E, Samara M, Kollia P, et al (2011). Different patterns of p16 immunoreactivity in cervical biopsies : correlation to lesion grade and HPV detection, with review of literature. Eur J Gynaecol Oncol, 32, 54-61.
- Lambert AF, Anshau F, Schmitt (2006). P16 expression in cervical premalignant and malignant lesions. Exp Mol Pathol, 80, 192-6. https://doi.org/10.1016/j.yexmp.2005.08.005
- Ministry of public health (2015). Cancer incidence in Thailand: Cervix uteri. In: Imsamran W, Chaiwerawattana A, Wiangnon S, Pongnikorn D, Suwanrungrung K, Sangrajrang S, Buasom R, eds. Cancer in Thailand, Volume VIII, 2010-2012. Bangkok; 48.
- Murphy N, Ring M, Hefron CC, et al (2005). P16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol, 58, 525-34. https://doi.org/10.1136/jcp.2004.018895
- Moore MA, Attasara P, khuhaprema T, et al (2010). Cancer epidemiology in mainland South-East Asia-past, present and future. Asian Pac J Cancer Prev, 11, 67-80.
- Nam EJ, Kim JW, Hong JW, et al (2008). Expression of the p16INK4a and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papilloma virus infection. J Gynecol Oncol, 19, 162-8. https://doi.org/10.3802/jgo.2008.19.3.162
- Ostor AG (1993). Natural history of cervical intraepithelial neoplasia: a critical review. Int Gynecol Pathol, 12, 186-92. https://doi.org/10.1097/00004347-199304000-00018
- Queriroz C, Silva TC, Venancio AF (2006). P16 expression as a potential prognostic marker in cervical pre-neoplastic and neoplatic lesion. Pathol Res Pract, 202 ,77-83. https://doi.org/10.1016/j.prp.2005.08.012
- Srisomboon J (2004). Cervical cancer: Diagnosis and Treatment. Bangkok, P.B. Book center .
- Tan GC, Sharifan NA, Shiran MS (2008). Utility of Ki 67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix. Asian Pac J Cancer Prev, 9, 781-84.
- Volgareva G, Zavalishina L, Andreeva Y, et al (2004). Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer, 4, 58. https://doi.org/10.1186/1471-2407-4-58
- Van Niekerk D, Guillaud M, Matisic J, et al (2007). P16 and MIB1 improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing. Gynecol Oncol, 107, 233-40 https://doi.org/10.1016/j.ygyno.2007.07.064
- Wang SS, Trunk M, Schiffman M, et al (2004). Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev, 13, 1355-60.
- Walts AE, Bose S (2009). P16, Ki-67, and BD ProExTMC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia. Hum Pathol, 40, 957-64. https://doi.org/10.1016/j.humpath.2008.12.005
- Agoff SN, Lin P, Morihara J, et al (2003). P16INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol, 16, 665-73. https://doi.org/10.1097/01.MP.0000077518.78046.0C
- Aslani FS, Safaei A, Pourjabali M, Momtahan M (2013). Evaluation of Ki67, P16 and CK17 markers in differentiating cervical intraepithelial neoplasia and benign lesions. Iran J Med Sci, 31, 15-21.
- Benevolo M, Mottolese M, Marandino F, Vorcaturo G (2006). Immunohistochemical expression of p16 is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol, 19, 384-91. https://doi.org/10.1038/modpathol.3800551
- Brown CA, Bogers J, Sahebali S, et al (2012). Role of Protein biomarkers in the detection of high-grade disease in cervical cancer screening programs. J Oncol, 1-11.
- Cones-Zamora P, Domenech-Peris A, Orantes-Casado FJ, et al (2009). Effect of human papillomavirus on cell cycle-related protein P16, Ki-67, Cyclin D1, P53 and ProEx C in precursor lesion of cervical cancinoma. Am J Clin Pathol, 132, 378-90. https://doi.org/10.1309/AJCPO0WY1VIFCYDC
- Cavalcante DM, Linhares LM, Pompeu ML, Giraldo PC, Eleuterio J (2012). The utility of p 16INK4a and Ki-67 to identify hig-grade squamous intraepithelial lesion in adolescents and young women. Indian J Med Microbiol, 55, 339-42.
- Dijkstra MG, Heideman DA, de Roy SC, et al (2010). P16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol, 63, 927-72.
- Evanthia A, Kostopoulou and George Koukoulis (2012). Immunohistochemistry in the diagnosis of squamous intraepithelial lesions of the uterine cervix. Human Papillomavirus and Related Diseases. A Clinical Perspective, Dr. Davy Vanden Broeck (Ed.): InTech, 41-64.
- Ferlay J, Soerjomataram I, Ervik M, et al (2012) GLOBOCAN, v1.0. Cancer incidence and mortality worldwide. IARC cancer base NO.11.
- Hariri J, Oster A (2007). The negative predictive value of p16 to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int J Gynecol Pathol, 26, 223-8. https://doi.org/10.1097/01.pgp.0000236942.51840.56
- Ishikawa M, Fujii T, Saito M, et al (2006). Overexpression of p16INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer, 16, 347-53. https://doi.org/10.1111/j.1525-1438.2006.00355.x
- Jackson JA, Kapur U, Ersahin C (2012). Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7- year follow-up. Int J Surg Pathol, 20, 146-53.
- Keating JT, Cviko A, Riethdorf S, et at (2001). Ki-67, Cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol, 25, 884-91. https://doi.org/10.1097/00000478-200107000-00006